• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Irinotecan HCl
    2 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Campto
    Pfizer
    RX
    partial basket chart
    Campto

    Topoisomerase I Inhibitor. Irinotecan HCl 20 mg/ml.
    CONC. FOR INFUS: 2 ml x 40 mg; 5 ml x
    100 mg, 15 ml x 300 mg. Dosage should
    be ajust. individ.
    Tmt. of pts. with metastat. colorect.
    cancer:
    In comb. with 5-FU and folinic
    acid in pts. without prior chemother. for
    metastat. dis.
    As a single agent in pts. who have failed
    an established 5-FU contain.
    tmt. regimen.
    Tmt. of pts. with small cell lung canerc.
    Tmt. of pts. with gastr. cancer.
    Irinotecan in comb. with leucovorin and
    5-FU for the first line
    tmt. of pts. with metastatic pancreat.
    adenocarcinoma.
    C/I: Hypersens.
    Chron. IBD and/or bowel obstruct.
    Lact.
    Bilirubin > 3 times the upper limit of the
    normal range.
    Severe bone marrow fail.
    WHO performance status > 2.
    Concom. use with St John’s Wort.
    Live attenuat. vaccin.

    Irinotecan Injection
    Pfizer
    RX
    partial basket chart
    Irinotecan Injection

    Topoisomerase I Inhibitor. Irinotecan HCl 20 mg/ml.
    CONC. FOR INFUS: 2 ml x 40 mg; 5 ml x
    100 mg, 25 ml x 500 mg. See lit.
    Metastat. colorectal cancer either in comb.
    with 5-fluorouracil and folinic acid in
    patients without prior chemother. for
    metastat. dis., or as single agent in pts.
    who have failed an established
    5-fluorouracil cont. tmt. regimen. Small
    cell lung cancer, gastric cancer.
    C/I: Chron. inflamm. bowel dis. and/or
    bowel obstruct., hypersens., pregn., lact.,
    bilirubin >3 times the upper limit of the
    normal range, severe bone marrow
    failure, WHO performance status > 2,
    concom. use with St. John’s wort.

    CLOSE